Officiating guests, experts and scholars gather at the forum to share new initiatives on the development of Chinese medicine


一眾主禮嘉賓與專家學者聚首論壇,為中醫藥發展帶來新思維

Date: 11 Jun 2018 (Monday)

Archive

Regional experts gather at HKBU forum to discuss development of Chinese medicine

浸大舉辦中醫中藥發展論壇 兩岸四地專家學者研討中醫優勢病種防治技術

To explore the competitive advantages of using Traditional Chinese Medicine (TCM) for prevention and treatment, and how to leverage the opportunities offered by the Belt and Road Initiative to promote Chinese medicine in countries along the Belt and Road trail, the Taiwan, Hong Kong and Macao Chinese Medicine Exchange and Cooperation Centre of the State Administration of Traditional Chinese Medicine (SATCM) and HKBU joined hands to organise the Fourth Forum (Hong Kong) on the Development of Chinese Medicine on 3 June on HKBU campus. This is enabled by the collaborative efforts of the School of Chinese Medicine (SCM) of HKBU and Pok Oi Hospital.
 
Carrying the theme “Promoting Techniques of Preventing and Treating Diseases for which Chinese Medicines has Advantages; Contributing to Belt and Road Initiative”, the forum attracted a 500-strong audience comprising government officials, leading figures in the Chinese medicine sector, Chinese medicine practitioners, students and teachers of SCM. A total of 12 scholars and experts from the Chinese mainland, Hong Kong, Taiwan and Macao were invited to shed light on their latest research findings in the treatment of diseases in which TCM has advantages, including malignant lymphoma, rheumatism, geriatric diseases, cervical spondylosis, knee pain, and more. They also elaborated on how the Greater Bay Area could seize the opportunities presented by the Belt and Road Initiative to promote Chinese medicine, and how Taiwan and Macao could ride on the Initiative to foster the development of Chinese medicine.
 
The officiating party of the opening ceremony included Mr Zhang Weijia, Deputy Head of Department of Personnel Education of SATCM; Professor Sophia Chan, Secretary for Food and Health of HKSAR Government; Dr Chan Hon-yee, Director of Health of HKSAR Government; Mr Li Shangqing, Deputy Director of Taiwan, Hong Kong and Macao Chinese Medicine Exchange and Cooperation Centre of SATCM; Professor Rick Wong, Vice-President (Research and Development) of HKBU; Professor Zhao Zhongzhen, Acting Dean of SCM of HKBU; Mr Lee Yuk-fat, Chairman of Board of Directors of Pok Oi Hospital; Professor Leung Ting-hung, Director of SCM of The Chinese University of Hong Kong; Professor Shen Jiangang, Associate Director of SCM of The University of Hong Kong; Mr Xu Qingfeng, Vice Director of Health and Family Planning Commission of Guangdong Province and Director of Traditional Chinese Medicine Bureau of Guangdong Province; Mr Wu Yichang, President of Taiwan and China Cross-Strait Antrodia Cinnamomea Industrial Development Association; Mr Shi Chongrong, President of Macau Association of Chinese Medicine Practitioners; Mr Chen Junfeng, Director of Coordination Department of the Liaison Office of the Central People’s Government in HKSAR; Dr Zhu En, President of Hong Kong Registered Chinese Medicine Practitioners Association; Mr Ouyang Bo, Vice Director of China Traditional Chinese Medicine Newspaper; Mr Li Fung-cheung, Chairman of Executive Council of Kowloon Chamber of Commerce; and Ms Ma Ninghui, Vice Director of Department of International Cooperation (Hong Kong, Macao and Taiwan Affairs Office) of SATCM.
 
Speaking at the ceremony, Mr Zhang Weijia said that while Chinese medicine had spread to 183 countries and regions, the number of overseas Chinese medicine centres along the Belt and Road trail had increased to 32 in the wake of the release of the Development Plan of the Belt and Road for Traditional Chinese Medicine (2016-2020) last year. China would continue to foster exchanges, technological connectivity and trade with those countries, develop the Chinese medicine healthcare industry and promote the inheritance of and innovation in Chinese medicine.
 
In her speech, Professor Sophia Chan pointed out that the HKSAR Government is committed to the development of Chinese medicine. Following the announcement made in the latest Policy Address on the establishment of a unit to coordinate and implement strategies and measures to promote the development of Chinese medicine in Hong Kong, the Government has reserved funding of HK$5 billion to support the development of Chinese medicine in Hong Kong. 

為深入研討中醫優勢病種,以及探討如何利用「一帶一路」的契機以推動中醫中藥走向「一帶一路」沿線國家,國家中醫藥管理局對台港澳中醫藥交流合作中心與浸會大學於6月3日在校園合辦「第四屆兩岸四地中醫中藥發展(香港)論壇」,並由浸大中醫藥學院和博愛醫院協辦。
 
論壇以「推廣中醫優勢病種防治技術,助力『一帶一路』」為題,吸引了逾500位人士出席,包括相關政府部門和中醫藥業界人士、中醫師和中醫藥師生等。來自內地、香港、台灣和澳門的12位專家學者應邀於論壇上,分享了對中醫藥治療惡性淋巴瘤、風濕病、老年疾病、頸椎病、頸痛、膝痛症等中醫臨床優勢病種的經驗和心得,以及暢談大灣區如何利用「一帶一路」傳承弘揚中醫藥,以至於台灣和澳門如何藉著「一帶一路」提供的機會,促進當地的中醫藥發展。
 
論壇開幕典禮由國家中醫藥管理局人事教育司副司長張為佳先生、特區政府食物及衞生局局長陳肇始教授、特區政府衞生署署長陳漢儀醫生、國家中醫藥管理局對台港澳中醫藥交流合作中心副主任李尚青先生、浸大副校長(研究及拓展)黃偉國教授、中醫藥學院署理院長趙中振教授、博愛醫院董事局主席李鋈發先生、中文大學中醫學院院長梁挺雄教授、香港大學中醫藥學院副院長沈劍剛教授、廣東省衞生和計劃生育委員會副主任兼任中醫藥局局長徐慶鋒先生、台灣中華海峽兩岸牛樟芝產業發展協會會長吳一昌先生、澳門中醫藥學會會長石崇榮先生、中聯辦協調部處長陳俊峰先生、香港註冊中醫學會會長朱恩博士、中國中醫藥報社副社長歐陽波先生、九龍總商會理事長李鳳翔先生、國家中醫藥管理局國際合作司副處長馬甯慧女士聯合主持。
 
張為佳副司長致辭時指出,現時中醫藥已發展至全球183個國家和地區,隨著國家於去年底發佈《中醫藥「一帶一路」發展規劃(2016-2020年)》,目前已在「一帶一路」沿線國家建立了32個中醫藥海外中心,並將繼續加強與這些國家的中醫藥交流、科技聯繫和貿易,發展中醫藥健康服務業和推動中醫藥傳承創新。
 
陳肇始局長表示特區政府銳意發展中醫藥,除了於去年的施政報告中宣佈成立專責發展中醫藥的小組,負責統籌和推動促進香港中醫藥發展的策略和措施,並將計劃設立五億港元的專項基金支持中醫藥發展。